FDA Import Refusal 799-5775331-4/40003/1 — SUN PHARMACEUTICAL
The FDA refused shipment 799-5775331-4/40003/1 from SUN PHARMACEUTICAL (India) on November 14, 2025. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- November 14, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 118,75